Kelly Paul Edward

Executive buyer

Director, Chief Operating Officer · RELMADA THERAPEUTICS, INC.

Every open-market stock purchase Kelly Paul Edward has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. This page tracks where those buys landed inside insider clusters and how the prices paid compare to where the stock trades now.

Total bought

$198.0K

Open-market buys

Companies

Last buy

Nov 5, 2025

Where the buys stand today

RLMD
RELMADA THERAPEUTICS, INC.
One purchase totalling $198.0K at an average of $2.20 per share. See all insider buying in RLMD →
Avg price paid
$2.20
Latest price
—
Market cap
Unknown

Cluster participation

Qualifying buys grouped with other insiders buying the same stock — the pattern this site exists to catch.

RLMDNov 5 – Nov 5, 2025
4 insiders$2.2M

All reported buys

Date	Ticker	Shares	Price	Value	Filing
Nov 5, 2025	RLMDcluster	90,000	$2.20	$198.0K	SEC ↗

Follow new qualifying clusters involving Kelly Paul Edward or other insiders

Explore qualifying clusters from public SEC filings. Pro adds email and Telegram notifications after detection.

Start a trial See pricing

About this data

Figures are parsed from Kelly Paul Edward's Form 4 filings on SEC EDGAR (CIK 1658544) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.

This page is informational and reflects public filing data. It is not investment advice.